Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Ron Squarer
Age : 54
Public asset : 4,787,264 USD
Linked companies : Travere Therapeutics, Inc. - Deciphera Pharmaceuticals, Inc. - ADC Therapeutics SA
Summary 
Ron Squarer holds the position of Chairman for ADC Therapeutics SA.

He is also on the board of Deciphera Pharmaceuticals LLC, Travere Therapeutics, Inc. and Deciphera Pharmaceuticals, Inc.

In his past career Mr. Squarer was Chief Executive Officer & Director at Array BioPharma, Inc., Principal at Smithkline Beecham Plc, Chief Commercial Officer & Senior Vice President at Hospira, Inc. and Senior Vice President-Business Development for Mayne Pharma Ltd.

He received an undergraduate degree from the University of California, Berkeley and an MBA from Kellogg School of Management.


Current positions of Ron Squarer 
NameTitle Since
Travere Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2017
Deciphera Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Independent Director 2019
ADC Therapeutics SA
(Biotechnology & Medical Research)
Chairman 2020
Deciphera Pharmaceuticals LLC Director 2019


Holdings of Ron Squarer 
NameEquities%Valuation
ADC Therapeutics SA (ADCT)
(Biotechnology & Medical Research)
990,9311.29%4,399,734 USD
Travere Therapeutics, Inc. (TVTX)
(Biotechnology & Medical Research)
17,8750.028%387,530 USD
Deciphera Pharmaceuticals, Inc. (DCPH)
(Biotechnology & Medical Research)
00.0000%0 USD


Ron Squarer: Personal Network 
Most Read News 
11/17Brazil's Buffett-backed StoneCo nearly doubles profits on more users, bigger prices
RE
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/18Gates Foundation pledges $7 billion for Africa as Ukraine war diverts donor cash
RE
11/17After Elon Musk's ultimatum, Twitter employees start exiting
RE
11/14Buffett-backed Nubank's revenue surges on robust customer growth
RE
11/12Musk to join G20 summit in Indonesia virtually - CNBC Indonesia
RE
11/18Musk's pay trial asks if Tesla's growth justifies $56 billion compensation
RE
11/14Sorrell's S4 Capital defies tech turmoil to maintain momentum
RE
11/16Twitter's ex-CEO Jack Dorsey says will not retake role
RE
More news


© 2022 People and Ownership :   
Ron Squarer : Connections